<DOC>
	<DOCNO>NCT00825396</DOCNO>
	<brief_summary>The purpose study determine safety tolerability topical C-KAD Ophthalmic Solution reduce intraocular pressure patient ocular hypertension .</brief_summary>
	<brief_title>An Open-Label Study Ophthalmic Solution Reduce Intraocular Pressure Patients With Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Both eye intraocular pressure range 2230 mmHg baseline Both eye best correct visual acuity well 20/50 Advanced glaucoma Closed barely open anterior chamber history angle closure</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>